Literature DB >> 20436760

Use of antidepressants: expansion beyond depression and anxiety.

Elisa F Cascade1, Amir H Kalali, Michael E Thase.   

Abstract

We investigated antidepressant prescriptions and reasons for use. According to our data, the top 10 molecules represent approximately 95% of total antidepressant prescriptions for both primary care physicians (PCPs) and psychiatrists. The primary difference between PCPs and psychiatrists was the increased use of buproprion and tricyclics/tetracyclics by psychiatrists. The selective serotonin reuptake inhibitors (SSRIs) and other newer antidepressants such as venlafaxine (Effexor) and buproprion (Wellbutrin) are used to treat depression, anxiety, and bipolar disorders. The noted exception is duloxetine (Cymbalta), which looks like a blend between the newer agents and the tricyclics where there is use beyond the traditional central nervous system (CNS) disorders into pain and migraine.

Entities:  

Keywords:  SSRI; antidepressant; prescription; primary care physician; psychiatrist; tricyclic

Year:  2007        PMID: 20436760      PMCID: PMC2861511     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  9 in total

1.  Treatment of depression: antidepressant monotherapy and combination therapy.

Authors:  Elisa F Cascade; Amir H Kalali; Pierre Blier
Journal:  Psychiatry (Edgmont)       Date:  2007-11

2.  Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.

Authors:  D A Kahn; G S Sachs; D J Printz; D Carpenter; J P Docherty; R Ross
Journal:  J Psychiatr Pract       Date:  2000-07       Impact factor: 1.325

3.  Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.

Authors:  Michael E Thase; Barbara R Haight; Nathalie Richard; Carol B Rockett; Melinda Mitton; Jack G Modell; Susan VanMeter; April E Harriett; Younghua Wang
Journal:  J Clin Psychiatry       Date:  2005-08       Impact factor: 4.384

4.  A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.

Authors:  Charles DeBattista; Brent Solvason; Jennifer Poirier; Ellen Kendrick; Emily Loraas
Journal:  J Clin Psychiatry       Date:  2005-07       Impact factor: 4.384

5.  Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

Authors:  R M Post; L L Altshuler; G S Leverich; M A Frye; W A Nolen; R W Kupka; T Suppes; S McElroy; P E Keck; K D Denicoff; H Grunze; J Walden; C M R Kitchen; J Mintz
Journal:  Br J Psychiatry       Date:  2006-08       Impact factor: 9.319

Review 6.  Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.

Authors:  Michael E Thase
Journal:  CNS Spectr       Date:  2004-11       Impact factor: 3.790

7.  Effectiveness of adjunctive antidepressant treatment for bipolar depression.

Authors:  Gary S Sachs; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael H Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245

8.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

9.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Authors:  Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

  9 in total
  5 in total

1.  Do antidepressant medications work?

Authors:  David A Casey
Journal:  P T       Date:  2013-03

2.  Trends in the dispensation of antidepressant drugs over the past decade (2000-2010) in Andalusia, Spain.

Authors:  M C González-López; C M Rodríguez-López; T Parrón-Carreño; J D Luna; E Del Pozo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-12-20       Impact factor: 4.328

3.  Pharmacokinetic interactions study between carvedilol and some antidepressants in rat liver microsomes - a comparative study.

Authors:  Maria Bianca Abrudan; Daniela Saveta Popa; Dana Maria Muntean; Ana Maria Gheldiu; Laurian Vlase
Journal:  Med Pharm Rep       Date:  2019-04-25

4.  Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors.

Authors:  Daniel O Erim; Jeannette T Bensen; James L Mohler; Elizabeth T H Fontham; Lixin Song; Laura Farnan; Scott E Delacroix; Edward S Peters; Theodora N Erim; Ronald C Chen; Bradley N Gaynes
Journal:  Cancer Med       Date:  2019-05-20       Impact factor: 4.452

5.  Neuroenhancement: State of the Art and Future Perspectives.

Authors:  Donatella Marazziti; Maria Teresa Avella; Tea Ivaldi; Stefania Palermo; Lucia Massa; Alessandra Della Vecchia; Lucia Basile; Federico Mucci
Journal:  Clin Neuropsychiatry       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.